Abstract
Primary adenocarcinomas of the bladder and urachus are extremely rare, accounting for 0.5–2.0% of all bladder malignancies (Williams and Chavda in Rev Urol 17(1):46–49, 2015). This chapter covers clinical presentation and management of bladder adenocarcinoma including survival outcomes, urachal adenocarcinoma and chemotherapy in metastatic disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aoun F, Peltier A, van Velthoven R. Bladder sparing robot-assisted laparoscopic en bloc resection of urachus and umbilicus for urachal adenocarcinoma. J Robot Surg. 2015;9(2):167–70.
Burnett AL, Epstein JI, Marshall FF. Adenocarcinoma of urinary bladder: classification and management. Urology. 1991;37(4):315–21.
Busto Martín LA, Janeiro Pais M, González Dacal J, Chantada Abal V, Busto Castañón L. Signet-ring cell adenocarcinoma of the bladder: case series between 1990–2009. Arch Esp Urol. 2010;63(2):150–3.
Correa JJ, Hakky TS, Spiess PE, Chuang T, Sexton WJ. Robotic-assisted partial cystectomy with en bloc excision of the urachus and the umbilicus for urachal adenocarcinoma. J Robot Surg. 2010;3(4):235–8.
DeFillipo N, Blute R, Klein LA. Signet-ring cell carcinoma of bladder. Evaluation of three cases with review of literature. Urology. 1987;29(5):479–83.
Dutta R, Abdelhalim A, Martin JW, Vernez SL, Faltas B, Lotan Y, Youssef RF. Effect of tumor location on survival in urinary bladder adenocarcinoma: a population-based analysis. Urol Oncol. 2016;34(12):531.e1–6.
Klaile Y, Schlack K, Boegemann M, Steinestel J, Schrader AJ, Krabbe LM. Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease? Transl Androl Urol. 2016;5(5):692–701.
Milhoua PM, Knoll A, Bleustein CB, Ghavamian R. Laparoscopic partial cystectomy for treatment of adenocarcinoma of the urachus. Urology. 2006;67(2):423.e15–7.
Pokuri VK, Sule N, Perfetto C, Duff M, Kopp C, Guru K, Shah D, George S. A novel treatment approach prolonging survival in an uncommon metastatic primary bladder adenocarcinoma. J Community Support Oncol. 2016;14(2):72–5.
Schultz RE, Bloch MJ, Tomaszewski JE, Brooks JS, Hanno PM. Mesonephric adenocarcinoma of the bladder. J Urol. 1984;132(2):263–5.
Teo M, Swan NC, McDermott RS. Sustained response of adenocarcinoma of the urinary bladder to FOLFOX plus bevacizumab. Nat Rev Urol. 2011;8(5):282–5.
Williams CR, Chavda K. En bloc robot-assisted laparoscopic partial cystectomy, urachal resection, and pelvic lymphadenectomy for urachal adenocarcinoma. Rev Urol. 2015;17(1):46–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Goonewardene, S.S., Persad, R., Motiwala, H., Albala, D. (2020). Histological Variants in Bladder Cancer—Adenocarcinoma. In: Management of Non-Muscle Invasive Bladder Cancer. Springer, Cham. https://doi.org/10.1007/978-3-030-28646-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-28646-0_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-28645-3
Online ISBN: 978-3-030-28646-0
eBook Packages: MedicineMedicine (R0)